ABSTRACT
ORIGINAL AR
INTRODUCTION Recurrent spontaneous abortion (RSA) hasbeenassociatedwithmanyetiologies.It occursin1to2%ofallwomenofreproductive age.1 An association between
autoantibod-ies and gestational loss has been identified, especially for antiphospholipid antibodies (APA).Otherantibodiessuchasthoseagainst thyroid components, nuclear antigens and deoxyribonucleicacid(DNA)fractions2have
alsobeenassociatedwithgestationallossand preeclampsia.3
Venous thrombosis in the mother has beenassociatedwithRSAinseveralseries.4,5
Acquired thrombophilia is associated with thrombophilicfactorswithnoinheritedchar-acteristics, such as anticardiolipin antibody (ACA)andlupusanticoagulant(LA).
ThedetectionofAPAsuchasACAand LAseemstobehigherinthefirsttrimesterin womenwhohaveantiphospholipidsyndrome (APS),butpositivetransientresultshavebeen detected in women without APS. APS and implantationsitethrombosiscanjustify5to 10%ofRSAandthemechanismofactionis notcompletelyclear.6
LA is an immunoglobulin that in-terferes with one or more phospholipid-dependent coagulation tests and leads to thromboembolicpredisposition.7Patients
withpersistentelevatedresultsareatrisk of arterial and venous thrombosis, gesta-tionallossandothercomplications,such asintrauterinegrowthrestriction.5
Simul-taneous presence of LA and other APA seems to have an important association withearlyabortion.8Inheritedfactorsfor
thrombophiliaincludeproteinC,proteinS andantithrombinIII(ATIII)deficiencies, factorVLeidenandG20210Amutations intheprothrombingeneandC677Tmu-tation in the methylenetetrahydrofolate reductase(MTHFR)gene.
Other APA have also been associated with RSA, such as antiphosphatidylserine and antiphosphatidylethanolamine. Some of theseantibodiesaredirectedtophosphatidyl ethanolamine-bindingplasmaproteins,suchas highmolecularweightkininogen.9
Thekinino-genconcentrationinreproductivetissuesand plasmahasbeenreportedtofluctuateduring ovulation,pregnancyandparturition.10What
governsthefluctuationofkininogenconcen-trationsremainstobeelucidated.Sugietal.9
demonstratedastrongassociationbetweenRSA andantiphosphatidylethanolamineantibodies. Studyingwomenwithrecurrentinvitrofertil-izationfailure,Matsubayashietal.11foundan
increasedincidenceofIgG-antiphosphatidyl-serine,whencomparedwithRSApatients.
Markersofdeficiencyinfolatemetabolic pathwayshavebeenassociatedwithRSA,in- cludingelevatedlevelsofplasmatichomocys-teine.12,13
Severalinheritedandacquiredcon-ditions can cause hyperhomocysteinemia,14
leadingtoincreasedriskofstroke,myocardial infarctionandperipheralarterialdisease.15The
C677TmutationintheMTHFRgeneleads toareductionintheactivityofthisenzyme, resultinginincreasedlevelsofplasmaticho-mocysteine.16Severalserieshavesuggestedan
association between hyperhomocysteinemia andRSA.12,13Othergestationalcomplications,
such as preeclampsia, abruptio placentae, intrauterinegrowthrestrictionandstillbirth have been associated with homozygous C677TintheMTHFRgene.17
Proteins C and S are natural plasmatic anticoagulants.15The prevalence of protein
Cdeficiencyinwomenwithgestationalloss rangesfrom4.7%13to25.5%.18
Ahighpreva-lenceofproteinSdeficiencyhasbeenfound in women with two or more spontaneous abortions:44.8%.ATIIIdeficiencyhasalso beenassociatedwithfirsttrimesterabortions18
andpreeclampsia.19
JoyceMaria Annicchino-Bizzacchi
RenatoPassiniJunior
BelmiroGonçalvesPereira
JoséCarlosGamadaSilva
JoãoLuizPintoeSilva
methylenetetrahydrofolate
reductasemutationinwomenwith
recurrentspontaneousabortions:
anewpathtothrombophilia?
UniversidadeEstadualdeCampinas,SãoPaulo,Brazil
CONTEXT: Recurrent spontaneous abortion (RSA)hasbeenassociatedwithvenousthrom-bosis in the mother. Acquired and inherited thrombophiliafactorsarepossiblecauses.
OBJECTIVE: To evaluate the association between thrombogenic factors and recurrent spontaneousabortion.
TYPEOFSTUDY:Case-controlstudy.
SETTING: Centro de Atenção Integral à SaúdedaMulher,UniversidadeEstadualde Campinas.
METHODS:40mlofbloodwascollectedfrom 88womenattendinganRSAclinicand88fertile women attending a family planning clinic, to evaluatethepresenceofacquiredandinherited thrombophilia factors. Anticardiolipin antibod-ies (ACA), lupus anticoagulant and deficiencantibod-ies of proteins C and S and antithrombin III were evaluatedbyenzyme-linkedimmunosorbentassay (ELISA),diluteRussellViperVenomtime(dRVVT), coagulometric and chromogenic methods. DNA wasamplifiedbythepolymerasechainreaction (PCR)tostudyfactorVLeidenandG20210Amuta-tionsintheprothrombingeneandC677Tmutation inthemethylenetetrahydrofolatereductase(MTHFR) gene.Datawereanalyzedusingoddsratiosanda regressionmodelforageadjustment.Fisher’sexact testwasusedtoevaluatestatisticalrelationships betweenassociatedfactorsandRSA.
RESULTS: ACA was detected in 11 women withRSAandonefertilewoman.Heterozygous C677Twasdetectedin59womenwithRSAand 35fertilewomen.ConcomitantpresenceofACA andC677TwasfoundineightwomenwithRSA andnofertilewomen(p<0.01).
DISCUSSION:Themeaningoftheassociation betweenC677TmutationintheMTHFRgeneand ACAisstillnotclear.Itispossiblethataninherited factorthatalonewouldnotstronglypredisposea womantothrombosiscould,whenassociatedwith anacquiredfactor,starttheprocessandincrease thelikelihoodofthrombosisexpression.
CONCLUSIONS: ACA and C677T in the MTHFR gene are statistically associated with RSA.Theassociationofthesetwoconditionsisa newfindinginthrombogenicfactorsandRSA.
KEY WORDS: Methylenetetrahydrofolate reductase (NADPH2) Thrombophilia.
AmutationinthefactorVgenehasbeen identified as the molecular basis for acti-vatedproteinC(aPC)resistanceandhasbeen namedfactorVLeiden.Thisleadstoahyper-coagulablestate.20Dizon-Townsonetal.21did
notdetectanynoassociationbetweenRSA andfactorVLeidenwhenstudyingwomen withRSAandfertilewomen.Despitethis,a clearassociationbetweenRSAandfactorV LeidenwasdetectedbyFokaetal.22
TheGtoAtransitionatthe20210posi-tion in the prothrombin gene is associated withelevatedprothrombinlevelsandisarisk factorforthrombosis.23Studying80women
withRSAand100fertilewomen,Fokaetal.22
detectedahigherfrequencyofpreeclampsia, abruptio placentae, intrauterine growth re-strictionandstillbirthamongthosewhowere carriersofthismutation.
It is well established that inherited or acquiredthrombophilicfactorsandtheircom- binationscanleadtoincreasedriskofthrom-bosis.6These combinations have also been
associatedwith2.2to14.3timesgreaterriskof RSA.24Theobjectiveofthepresentstudywas
toevaluatetheassociationbetweenthepresence ofthrombophilicfactorsandRSA.
METHODS Thiswasacase-controlstudythatincluded 88womenwithRSAwhoweresequentiallyat-tendinganRSAclinicatUniversidadeEstadual de Campinas (Centro de Atenção Integral à Saúde da Mulher) as outpatients (Group 1) and 88 fertile women with at least one suc-cessfulpregnancywhowereattendingafamily planningclinicatthesameinstitution(Group 2),fromJanuary1999toAugust2000.The women in Group 2 had no history of RSA, stillbirth, thromboembolic episodes, arte-rialhypertension,badobstetricsorlowbirth weight.ThepatientsinGroup1werematched withthecontrolsinGroup2byage(five-year
groups)andrace(whiteornon-white).40ml ofbloodwascollectedtoevaluatethepresence ofacquired(ACAandLA)andinheritedfactors (proteinC,proteinSandATIIIdeficiencies, factorVLeidenandG20210Amutationsin theprothrombingeneandC677Tmutations intheMTHFRgene).
Enzyme-linked immunosorbent assay (ELISA) was performed as previously de-scribed,25usinghighpositivecontrolswith
knownimmunoglobulinG(IgG)andimmu- noglobulinM(IgM)concentrations(calibra-tionseraLAPL-MP-005andLAPL-GP-005 from Louisville, Kentucky) and a normal donor as the negative control, in order to detectACA.Forquantitativedetermination ofACA,ELISAwasusedaccordingtothe manufacturer’sinstructionsandthestandard ELISAprocedures.In-housecalibratorswere usedforstandardization.Negativecontrols were included in the assays to confirm negativetestresults.Thesenegativecontrols consisted of negative serum tested in our laboratoryaccordingtostandardprocedures. Positivetestresultsforpatientswereselected bymeansofpositivecontrolsfromLouisville. The absorbance was determined using a photometersetat450nm.Thecutoffvalues predefinedbythemanufacturerswere:IgG >20unitsandIgM>20units.Theinter-assay variation was 2.9-7.4% for IgG and 2.3-5.1% for IgM. Mean values were also determined,andtheresultswerecompared usingmultiplesofthemean.
LA was detected by the dilute Russell ViperVenomTime(dRVVT),usingtheOr-ganonTeknikakit:ViperquikTMLA-testand
ViperquikTMLA-check.Thefinalresultwas
expressedasarelationshipbetween“test”and “check”results.Whenthisratiowasgreater than1.20,aconfirmatorytestwasperformed usinga50%mixture.Resultsgreaterthan2.0 wereconsideredpositive.
ProteinS(PS)activitywasevaluatedvia thecoagulometricmethodusingtheBioclot PSkit.Normaldilutedplasmawasmixedwith PS-deficientplasma.Thismixturewasactivat-edbyactivatedfactorX+activatedproteinC +phospholipids.Aftertheadditionofcalcium chloride,theprolongationofclottingtimewas consideredtobeproportionaltotheproteinS concentrationinthepatient’splasma.Normal activityrangedfrom55%to160%.
Protein C activity was evaluated by the prolongationoftheactivatedpartialthrombo- plastintime(APTT),usingsoutherncopper-headsnakepoisontoactivateit.Theprotein C assay was performed using the Dade kit fromBaxterDiagnostics,Inc.Normalactivity rangedfrom72%to142%.
ATIIIfunctionallevelsweredetermined usingplasmadilutedwithATIII,heparinand excessthrombin.AnATIII-thrombin-heparin complex was formed, and the remaining thrombincatalyzedp-nitroanilinereleaseson a chromogenic substrate.These were mea-suredat405nmandviewedonacalibration curve.TheChromostrate®kitfromOrganon
Teknikawasused,andnormalvaluesranged from85%to125%.
GenomicDNAwasextractedfromperiph-eralbloodbyastandardmethod.26
Thepoly-merasechainreaction(PCR)wasusedtoassay thefactorVLeidenmutation,thethermolabile MTHFRC677Tmutationandtheprothrom- binG20210Amutation.Amplificationoffac-torVLeidenwasperformedusingamixture of54mMTrisHCl(pH8.8),5.4mMMgCl2, 5.4µM EDTA, 13.3 mM (NH4)2SO4, 8%
DMSO,8mMβ-mercaptoethanol,0.4mg/ml BSA,0.8mMofeachnucleosidetriphosphate, 200 ng of each forward and reverse primer, 250to500ngofgenomeDNAand2UTaq polymerase.Theamplificationwasperformed for36cyclesof91°C(40seconds),55°C(40 seconds)and71°C(twominutes).
Table1.Thrombophilicfactordistributionin88womenwithrecurrentabortion(Group1)and88fertilewomen(Group2) attendedatanoutpatientclinicinBrazil
Group1 n(%)
Group2 n(%)
OR (95%CI)
Age-adjustedOR(1) (95%CI)
Anticardiolipinantibodies 11 (12.5) 1 (1.1) 12.4(1.5to98.5) 12.9(1.5to109.5) Lupusanticoagulant 1 (1.1) 0 (0) - -ProteinSdeficiency 1 (1.1) 0 (0) - -ProteinCdeficiency 2 (2.3) 0 (0) - -ATIIIdeficiency 1 (1.1) 0 (0) - -FactorVLeiden 3 (3.4) 0 (0) 7.2(0.3to142.4) -G20210Aprothrombin 1 (1.1) 1 (1.1) 1.0(0.06to16.2) 1.0(0.04to22.8) C677TmutationinMTHFRgene 59 (67.0) 35 (39.8) 3.1(1.7to5.7) 3.3(1.6to6.6)
(1)Ageadjustmentwasperformedusingamultipleregressionmodel.
For MTHFR and prothrombin, ampli-fications were performed in separate 50µl reactions containing 10 mMTris HCl (pH 8.3),50mMKCl,1.5mMMgCl2,0.2mM ofeachnucleosidetriphosphate,0.4µMof eachforwardandreverseprimerand2.5Uof Taq polymerase.The PCR parameters were 38cyclesof94°C(30seconds),54°C(30 seconds)and72°C(30seconds).Theinitial cyclewasprecededby9minutesat94°C,so astoactivateAmpliTaqGoldpolymerasein additiontodenaturingthetemplate,andthe lastcyclewasfollowedby5minutesat72°C. ThePCRproductsweredigestedwiththeap-propriaterestrictionenzyme.Afterdigestion, PCRproductsweresubmittedtoelectropho-resison2%agarminigelscontainingethidium bromideat120Vfor1hour.
ForfactorVLeiden,MnIIdigestionof the267-bpPCRproductyieldedfragments of163,67and37bpforthenormalallele. Thedigestionproductsofthemutantallele were 200 and 67 bp. For MTHFR, HynfI did not cleave the 198-bp PCR product of thenormalallele,whereasthemutantallele yieldedfragmentsof175bpand23bpafter HinfIdigestion.
For prothrombin, HindIII digestion yieldedintact345-bpproductforthenormal alleleandtwofragmentsof322and23bpfor themutantallele.Foreachlocus,heterozygous individualsexhibitedbothnormalandmutant digestionproducts.ThePCRassaycontrols includedDNAfromasubjectwithsubject, anormalsubjectandablankwaterrunfor eachanalysis.
The data were analyzed using the odds ratio (OR) and a regression model for age-adjustment. Fisher’s exact test was used to evaluate statistical relationships between RSA and the associated factors.The results wereconsideredstatisticallysignificantwhen
pvalueswerelessthan5%,foralpha=0.05 andbeta=0.20.
The ethical principles of the Helsinki DeclarationoftheWorldMedicalAssociation werefollowedinthisstudy.TheEthicsCom-mitteeofUniversidadeEstadualdeCampinas, Brazil,approvedthisstudy.
RESULTS Themeanagewas30.4yearsforGroup 1and29.7forGroup2.Thetotalnumber of pregnancies for patients from Group 1 was 346, which ended as 26 deliveries and 320spontaneousabortions.InGroup2,the totalnumberofpregnancieswas181,andall of them ended as deliveries. In each group studied,61.4%ofthewomenwerewhite.In
Table2. HomozygousandheterozygousC677Tmutationinthemethylenetetrahy-drofolatereductasegenein88womenwithrecurrentabortion(Group1)and88 fertilewomen(Group2)attendedatanoutpatientclinicinBrazil
C677TmutationinMTHFRgene Group1 Group2 p
(n) % (n) %
Homozygous,TT[a] 12 13.6 9 10.2 aversusc=0.06 Heterozygous,CT[b] 47 53.4 26 29.5 bversusc=0.0003 Normal,CC[c] 29 33.0 53 60.2
Total 88 100.0 88 100.00
MTHFR=methylenetetrahydrofolatereductase.
Table3.Methylenetetrahydrofolatereductasegenealleledistributionin88women withrecurrentabortion(Group1)and88fertilewomen(Group2)attendedatan outpatientclinicinBrazil
Allele Group1 Group2 p
(n) % (n) %
Mutant(T) 71 40.3 44 25.0 0.002 Normal(CC) 105 59.7 132 75.0
Total 176 100.0 176 100.00
Group1,55.7%hadhadthreepregnancies and44.3%hadhadfourormore.InGroup2, 36.4%hadhadjustonepregnancy.InGroup 1,64.8%hadhadthreegestationallossesand 35.2%hadhadfourormorelosses.ACAwas detectedinelevenwomenfromGroup1and inonewomanfromGroup2(OR12.4;1.5to 98.5).TheC677TmutationintheMTHFR genewasdetectedin59womenfromGroup 1and35fromGroup2(OR3.1;1.7to5.7). TheseresultscanbeobservedinTable1.
Table2showsthedistributionofhomo-zygous and heteroTable2showsthedistributionofhomo-zygous C677T mutation inthetwogroups.Astatisticallysignificant difference was found when women with heterozygousmutationwerecomparedwith normalwomen.
Table 3 shows the allele distribution of C677Tmutationbetweenthegroupsstudied. Themutantallele(T)wasfoundin40.3% ofthewomeninGroup1andin25%ofthe womeninGroup2.
Nostatisticallysignificantdifferenceswere detectedinthedistributionofthrombophilic factorswhenpatientsweredividedintowhite andnon-whiteskincolor.
Theanalysisofassociatedfactorsandtheir comparisonbetweenthegroupsstudiedshowed thatACAandtheheterozygousC677Tmuta-tionintheMTHFRgeneweresimultaneously presentineightwomenfromGroup1andno one from Group 2, and this difference was statisticallysignificant.Theassociationbetween ACAandthehomozygousC677Tmutation in the MTHFR gene showed no statistical difference between the two groups; nor did theassociationsbetweenACAandtheother
thrombophilicfactorsstudied.Theserelation-shipscanbeseeninTable4.
Likewise, the associations between the heterozygousC677TmutationintheMTHFR geneandtheotherfactorsstudiedshowedno statisticallysignificantdifferencebetweenthe twogroups.ThehomozygousC677Tmutation intheMTHFRgeneshowednoassociation withanythrombophilicfactorstudied.
DISCUSSION Inthisstudywelookedforassociationsof inheritedandacquiredthrombophilicfactors amongpatientswithandwithoutrecurrent spontaneousabortions.Patientswerematched byage,inordertotrytominimizeanypossible unknowneffectofagevariationonRSA,or anypossibleeffectofacquiredfactors(ACA andLA)onolderwomen,regardlessofthe fact that no differences in the frequencies of these antibodies have been described for severalagegroups.27
Itisknownthattheprevalenceofgenetic diseasesvariesindifferentraces.AstheBra-zilian population is highly heterogeneous, patientswerealsomatchedbyrace.Ahigher prevalenceoffactorVLeidenamongCauca-sianshasbeendescribed.28Itispossiblethat
othermutationsalsopresenthigherprevalence inthisracialgroup.IntheBrazilianpopula-tion,ahigherprevalenceoffactorVLeidenhas beendetectedinCaucasians,andithasrarely beendetectedinblackpeopleandIndians.29
36.4%ofthewomeninGroup2werepri-miparous.Althoughwecouldnotknowhow thenextpregnancieswoulddevelopforthis group,primiparouswomenwereincludedas participantsinthecontrolgroup,inthesame wayaspreviouslydescribedinotherseries.30,31
Afteronesuccessfulpregnancy,approximately 3%ofwomenwillexperienceaspontaneous abortion.1Consideringthisprobability,only
onewomanfromGroup2wouldbeexpected tohavethiscomplicationandthisproportion wouldnotbeenoughtochangeourresults.
ACApositivityoccurredin12.5%ofthe womenwhohadRSA,andthiscoincideswith the results in the literature.5 Among fertile
women,itwasdetectedin1.1%.Thepreva-lenceofACAdescribedinnormalobstetric populationsrangesfrom2.9to3.6%.32
LA was detected in one patient from Group 1 and none from Group 2. Several serieshavebeendescribedthatshowanas-sociationbetweenLAandRSA.5,8However,
LA levels can vary during pregnancy,7 and
persistentlyelevatedlevelsarestronglyassoci-atedwithgestationalloss.5Wedidnotfinda
goodcorrelationbetweenthistestandRSA inthisgroupofpatients.Thereisachance
thatthisfactorisnotanimportantonefor ourpopulation.
Theprevalenceofdeficienciesofprotein C,proteinSandATIIIdidnotdifferbetween thegroupsstudied.Ahigherriskofspontane-ousabortioninwomenwiththesedeficiencies hasbeenreported.33SinceproteinCdeficiency
canaffect10to15%ofyoungindividualswith recurrentvenousthrombosis20andproteinS
deficiency occurs in 2.2% of patients with venousthrombosis,15weinvestigatedwhether
thrombosisatanimplantationsitecouldlead torecurrentabortioninwomenwiththesede-ficiencies.Thishypothesiswasnotconfirmed byourresults.TwowomenfromGroup1and nonefromGroup2hadproteinCdeficiency. As the incidence of this deficiency in the generalpopulationis1/33,000individuals,15
a statistically significant difference might perhaps be detected with a greater number ofpatients.
Women of reproductive age who are deficient in protein C, protein S or ATIII haveathreetimeshigherriskofthromboem-bolicdiseasethandomenofthesameage.34
Womenwithseriouseffectsfromastrokeor myocardial infarction may have more
dif-Table4.Associationsbetweenanticardiolipinantibodiesandotherthrombophilic factors:distributionin88womenwithrecurrentabortion(Group1)and88fertile women(Group2)attendedatanoutpatientclinicinBrazil
Factorassociations Group1 Group2 p*
(n) % (n) %
ACAwith: Lupusanticoagulant 0 0 0 0 1.00 ProteinCdeficiency 1 1.1 0 0 1.00 ProteinSdeficiency 0 0 0 0 1.00 ATIIIdeficiency 1 1.1 0 0 1.00 LeidenfactorV 0 0 0 0 1.00 G20210Aprothrombin 0 0 0 0 1.00 HeterozygousC677T 8 9.1 0 0 <0.01 HomozygousC677T 0 0 0 0 1.00
Total (10) (11.3) (0) (0)
*Fisher’sexacttest.ACA=anticardiolipinantibody.
Table5.ListofsomeserieswithorwithoutanassociationbetweenfactorVLeiden andrecurrentspontaneousabortion
Author Year Cases Controls p
Raietal.30 1996 70 70 0.02
Balashetal.31 1997 55 50 NS
Dizon-Townsonetal.21 1997 40 25 NS
Grandoneetal.37 1997 43 118 0.011
Paueretal.38 1998 84 84 NS
Kuttehetal.39 1999 50 50 NS
Souzaetal.40 1999 56 384 0.03
Fokaetal.22 2000 80 100 0.003
Wramsbyetal.41 2000 84 69 0.024
NS=notsignificant.
ficulty becoming mothers, as much due to theirclinicalconditionasduetorestrictions on social relations.Thus, the evaluation of womenwithRSAcouldexcludeseriouscases inaninvoluntarymanner,therebymodifying theresults.
Therewerenostatisticallysignificantdif-ferencesinthefrequenciesoffactorVLeiden andG20210Amutationintheprothrombin genebetweenthetwogroups.Theliterature shows large variation in the importance of thesemutationsinrelationtoRSA.Somese-rieshavedemonstratedanassociationbetween activatedproteinCresistanceandabortions,30
butthepictureisnotsoclearwhentryingto implicatefactorVLeidenasresponsiblefor thisresistanceintheabortionseries.35
Some authors have confirmed an asso-ciation between factor V Leiden and RSA, butothershavenot,ascanbeseeninTable 5.Ourresultsdidnotdemonstratesuchan association. Although three women from Group 1 were detected as factor V Leiden carriers,therewerenoneinGroup2.Again, theuseofalargersamplesizewouldperhaps give rise to a significant difference between thetwogroups.
G20210Acarriershavehigherprothrom-binlevelsandareatgreaterriskofthrombosis thanarecontrols.23Ahigherriskofprimary
abortion was detected in women with this mutationthanincontrols.22Ourresults,with
asimilarnumberofpatients,didnotshowa significantdifferenceinG20210Aprevalence betweenthegroupsstudied.Morestudiesare necessary for a definitive conclusion about theimportanceofthismutationforRSAto bereached.
TheevaluationoftheC677Tmutationin theMTHFRgeneresultedincuriousdata.We observedanassociationofthismutationwith RSA,butsuchanassociationisnotcompletely clearintheliterature.Someauthorsagreethat C677T,asacauseofhyperhomocysteinemia, couldleadtoRSA,17,22butothersdonot.36,37
Homozygous C677T was detected in twelvewomenfromGroup1andinninefrom Group2.Thisdifferencewasnotsignificant. Thehighnumberofwomenwithhomozy-gous C677T MTHFR who had successful pregnancies (nine women from Group 2) suggeststhatthismutationisnotanessential conditionforabadgestationalresult.None oftheseninewomenhadACAinassociation withhomozygousC677TMTHFR.
with the literature. Some series in which C677T is classified as homozygous or heterozygoushaveshownaclearpredomi-nance of statistically significant homozy-gosityinRSA.16,21Lissaketal.38described
the importance of heterozygous C677T inRSA,butstatedthatmoreserieswould benecessarytoconfirmthis.Homozygous individualshavehighhomocysteinelevels, but increased levels can also be seen in heterozygousindividuals.
Nonetheless,theallelefrequencyofthe C677TmutationintheMTHFRgenewas higherinGroup1,withastatisticallysignifi-cantdifferencebetweenthetwogroups.This may direct new investigations towards the importanceofheterozygousC677Tmutation inwomenwithRSA.
Theconceptthatseveralfactorsinteract to create thrombosis is well established.39
The action of thrombophilic factors dur-ing placentation may become amplified, therebygivingrisetomodificationsinpla-cental circulation.These events could lead
tospontaneousabortionorothergestational complications, such as intrauterine growth restrictionandstillbirth.
Several congenital and acquired factors mustacttogethertosuppressthepotentan-tithromboticmechanism.39Theassociationof
ACAandheterozygousC677Tmutationwas detectedineightwomenfromGroup1and nonefromGroup2,andthisdifferencewas statisticallysignificant.
Themeaningofthisassociationisstillnot clear.Itispossiblethataninheritedfactorthat alonewouldnotstronglypredisposeawoman tothrombosiscould,whenassociatedwithan acquiredfactor,startthethrombosisprocess.
The association between heterozygous C677TmutationintheMTHFRgeneand ACAmayincreasethelikelihoodofthrom-bosisexpression.Itisknownthatpersistently elevatedserumlevelsofACAareassociated with RSA.40 Positive results for ACA may
be the starting point for the process of thrombosis.Webelievethatthiskindofas-sociationmaybethekeytounderstanding
themechanismsforseveraldiseases,suchas RSA,cancerorcardiacinfarction,andshould befurtherinvestigated.
Thereisnoevidenceintheliteraturethat thiskindofassociationisabsolutelynecessary forthefullmanifestationoftheantiphospho-lipidsyndrome.However,itispossiblethatan inheritedfactor,suchasC677T,mayactasage-neticpredisposingfactorthatinteractswiththe antiphospholipidantibodiestofullymanifest theirclinicalaspects.Moreover,wecannotstate whethersuchassociationsarethecauseofthe antiphospholipidsyndromeorwhetherC677T istheinducerofanticardiolipinantibodies.But wecanwonderwhetherthisassociationmight benecessaryforACAmanifestation.
CONCLUSIONS ACAandheterozygousC677Tmutation intheMTHFRgenepresentedastatisticalas-sociationwithRSA.Theassociationofthese twoconditionsisanewfindinginthrombo-genicfactorsforRSA,andmaycontributeto agreaterunderstandingofthisevent.
1. Regan L, Braude PR,Trembath PL. Influence of past repro-ductive performance on risk of spontaneous abortion. BMJ. 1989;299(6698)541-5.
2. QureshiF,YangY,JaquesSM,etal.Anti-DNAantibodiescross- reactingwithlaminininhibittrophoblastattachmentandmigra-tion:implicationsforrecurrentpregnancylossinSLEpatients. AmJReprodImmunol.2000;44(3):136-42.
3. MecacciF,ParrettiE,CioniR,etal.Thyroidautoimmunityandits associationwithnon-organ-specificantibodiesandsubclinicalal-terationsofthyroidfunctioninwomenwithahistoryofpregnancy lossorpreeclampsia.JReprodImmunol.2000;46(1):39-50. 4. HughesGR.Thrombosis,abortion,cerebraldiseaseandthelupus
anticoagulant.BrMedJ(ClinResEd).1983;287(6399):1088-9. 5. TriplettDA.Obstetricalcomplicationsassociatedwithantiphos-pholipidantibodies.In:CoulamCB,FaulkWP,McIntyreJA, editors.Immunologicalobstetrics.London:NortonMedicalBooks; 1992.p.377-403.
6. YounisJS,OhelG,BrennerB,HaddadS,LanirN,Ben-Ami M.Theeffectofthrombophylaxisonpregnancyoutcomein patientswithrecurrentpregnancylossassociatedwithfactorV Leidenmutation.BJOG.2000;107(3):415-9.
7. LockshinMD,QamarT,LevyRA.Anticardiolipinandrelated antibodies:thrombosisandfetaldeath.In:ScottJS,BirdHA, editors.Pregnancy,autoimmunityandconnectivetissuedisorders. Oxford:OxfordUniversityPress;1990.p.185-211. 8. MacLean MA, Cumming GP, McCall F,Walker ID,Walker
JJ.The prevalence of lupus anticoagulant and anticardiolipin antibodiesinwomenwithahistoryoffirsttrimestermiscarriages. BrJObstetGynaecol.1994;101(2):103-6.
9. SugiT,KatsunumaJ,IzumiS,McIntyreJA,MakinoT.Prevalence and heterogeneity of antiphosphatidylethanolamine antibodies in patients with recurrent early pregnancy losses. Fertil Steril. 1999;71(6):1060-65.
10. HossainAM,WhitmanGF,KhanI.Kininogenpresentin rat reproductive tissues is apparently synthesized by the liver,notbythereproductivesystem.AmJObstetGynecol. 1995;173(3Pt1):830-4.
11. MatsubayashiH,SugiT,AraiT,etal.Differentantiphospholipid antibodyspecificitiesarefoundinassociationwithearlyrepeated pregnancylossversusrecurrentIVF-failurepatients.AmJReprod Immunol.2001;46(5):323-9.
12. WoutersMG,BoersGH,BlomHJ,etal.Hyperhomocysteinemia: ariskfactorinwomenwithunexplainedrecurrentearlypregnancy loss.FertilSteril.1993;60(5):820-5.
13. CoumansAB,HuijgensPC,JakobsC,etal.Haemostaticand metabolicabnormalitiesinwomenwithunexplainedrecurrent abortion.HumReprod.1999;14(1):211-4.
14. NelenWL,BlomHJ,SteegersEA,denHeijerM,ThomasCM, EskesTK.Homocysteineandfolatelevelsasriskfactorsforrecur-rentearlypregnancyloss.ObstetGynecol.2000;95(4):519-24. 15. De StefanoV, Finazzi G, Mannucci PM. Inherited thrombo-philia:pathogenesis,clinicalsyndromes,andmanagement.Blood. 1996;87(9):3531-44.
16. LaneDA,MannucciPM,BauerKA,etal.Inheritedthrombo-philia:Part1.ThrombHaemost.1996;76(5):651-62. 17. KupfermincMJ,EldorA,SteinmanN,etal.Increasedfrequencyof
geneticthrombophiliainwomenwithcomplicationsofpregnancy. NEnglJMed.1999;340(1):9-13.
18. Ogasawara MS, Aoki K, Katano K, Ozaki Y, Suzumori K. FactorXIIbutnotproteinC,proteinS,antithrombinIII,or factorXIIIisapredictorofrecurrentmiscarriage.FertilSteril. 2001;75(5):916-9.
19. GalstianA,BeerAE,RobertsJM,CoulamCB,FaulkWP.Im-munologyofpreeclampsia.In:CoulamCB,FaulkWP,McIntyre JA,editors.Immunologicalobstetrics.London:NortonMedical Books;1992.p.503-15.
20. DahlbackB.TheproteinCanticoagulantsystem:inheriteddefects asbasisforvenousthrombosis.ThrombRes.1995;77(1):1-43. 21. Dizon-Townson DS, Kinney S, Branch DW, Ward K.The
factorVLeidenmutationisnotacommoncauseofrecurrent miscarriage.JReprodImmunol.1997;34(3):217-23. 22. FokaZJ,LambropoulosAF,SaravelosH,etal.FactorVleidenand
prothrombinG20210Amutations,butnotmethylenetetrahydro-folatereductaseC677T,areassociatedwithrecurrentmiscarriages. HumReprod.2000;15(2):458-62.
23. PoortSR,RosendaalFR,ReitsmaPH,BertinaRM.Acommon geneticvariationinthe3’-untranslatedregionoftheprothrombin geneisassociatedwithelevatedplasmaprothrombinlevelsandan increaseinvenousthrombosis.Blood.1996;88(10):3698-703. 24. BlumenfeldZ,BrennerB.Thrombophilia-associatedpregnancy
wastage.FertilSteril.1999;72(5):765-74.
25. TriplettDA,BarnaL,UngerG.Laboratoryidentificationsoflupus anticoagulants.In:XIVthCongressoftheInternationalSocietyon
ThrombosisandHaemostasis.NewYork,NewYork,USA.July4-9, 1993.NewYork:NewYorkHilton&Towers;1993.p.70-9. 26.
SambrookJ,FritschEF,ManiatisT.Molecularcloning:alabora-torymanual.2aed.NewYork:ColdSpringHarbor,ColdSpring
HarborLaboratory;1989.
27. Ruiz AM, Kwak JY, Kwak FM, Beer AE. Impact of age on reproductive outcome in women with recurrent spontaneous abortionsandinfertilityofimmuneetiology.AmJReprodIm-munol.1996;35(4):408-14.
28. ReesDC,CoxM,CleggJB.WorlddistributionoffactorVLeiden. Lancet.1995;346(8983):1133-4.
29. ArrudaVR,vonZubenPM,SoaresMC,MenezesR,Anni- chino-BizzacchiJM,CostaFF.VerylowincidenceofArg506-->GinmutationinthefactorVgeneamongtheAmazonian IndiansandtheBrazilianblackpopulation.ThrombHaemost. 1996;75(5):860-1.
AUTHORS INFORMATION
Egle Couto, MD, PhD. Department of Gynecology and Obstetrics, Universidade Estadual de Campinas, São Paulo,Brazil.
Ricardo Barini, MD, PhD. Department of Gynecology and Obstetrics, Universidade Estadual de Campinas, São Paulo,Brazil.
Renata Zaccaria, MD. Department of Gynecology and Obstetrics, Universidade Estadual de Campinas, São Paulo,Brazil.
JoyceMariaAnnicchino-Bizzacchi,MD,PhD.Departmentof InternalMedicine,DisciplineofHematology,Universidade EstadualdeCampinas,SãoPaulo,Brazil.
RenatoPassiniJunior,MD,PhD.DepartmentofGynecology andObstetrics,UniversidadeEstadualdeCampinas,São Paulo,Brazil.
BelmiroGonçalvesPereira,MD,PhD .DepartmentofGynecol-ogyandObstetrics,UniversidadeEstadualdeCampinas, SãoPaulo,Brazil.
JoséCarlosGamadaSilva,MD,PhD. DepartmentofGynecol-ogyandObstetrics,UniversidadeEstadualdeCampinas, SãoPaulo,Brazil.
JoãoLuizPintoeSilva,MD,PhD.DepartmentofGynecology andObstetrics,UniversidadeEstadualdeCampinas,São Paulo,Brazil
Addressforcorrespondence: EgleCouto
RuaQuirinoA.Campos,75—Apto.21—Cambuí Campinas(SP)—Brasil—CEP13024-460 Tel.(+5519)3788-9477—Fax(+5519)3788-9304 E-mail:[email protected]
Copyright©2005,AssociaçãoPaulistadeMedicina
RESUMO
Associação entre anticorpo anticardiolipina e mutação C677T na metileno tetrahidrofolato redutase em mulherescomabortoespontâneorecorrente:umnovocaminhonatrombofilia?
CONTEXTO:Oabortoespontâneorecorrentejáfoiassociadoaváriosfatoresetiológicoseàtrombose
materna.Fatoresdetrombofiliaadquiridosehereditáriospodemsercausasdesteseventos.
OBJETIVO:Avaliaraassociaçãoentrefatoresdetrombofiliaeabortoespontâneorecorrente.
TIPODEESTUDO:Caso-controle.
LOCAL:CentrodeAtençãoIntegralàSaúdedaMulher,UniversidadeEstadualdeCampinas,SãoPaulo,
Brasil.
MÉTODOS:
Foramretirados40mldesanguede88mulherescomabortoespontâneorecorrentedoAmbu-latóriodeAbortoRecorrentee88mulheresférteisdoAmbulatóriodePlanejamentoFamiliar,pareadaspor idadeeraça,parapesquisarfatoresdetrombofiliaadquiridosehereditários.Oanticorpoanticardiolipina (ACA),anticoagulantelúpico(LA)eadeficiênciadasproteínasC,SeantitrombinaIIIforampesquisados porELISA(enzyme-linkekimmunosorbentassay),dRVVT(diluteRusselViperVenomTime,dRVVT)emétodos coagulométricoecromogênico.Oácidodesoxirribonucléico(DNA)foiamplificadopelatécnicadereação emcadeiadapolimerase(PCR)paraoestudodasmutaçõesfatorVdeLeiden,G20210Anogeneda protrombinaeC677Tnogenedaenzimametilenotetrahidrofolatoredutase(MTHFR).
RESULTADOS:OACAfoiencontradoem11mulherescomRSAeemumamulherfértil[OR12.4(IC95%
1.5a98.5)].AmutaçãoC677Theterozigotafoiencontradaem59mulherescomRSAeem35mulheres férteis[OR3.1(IC95%1.7a5.7)].ApresençaconcomitantedoACAedamutaçãoC677Theterozigotafoi encontradaemoitomulherescomabortoespontâneorecorrenteeemnenhumamulherfértil(p<0,01).
DISCUSSÃO:OsignificadodaassociaçãoentreamutaçãoheterozigotaC677TnogenedaMTHFReo
anticorpoanticardiolipinanãoestáclaro.Pode-sesuporqueumfatorhereditárioque,isolado,nãopre-disporiafortementeumindivíduoàtrombosepoderia,emassociaçãocomumfatoradquirido,deflagrar oprocessoeintensificaraexpressãodatrombose.
CONCLUSÕES:OACAeamutaçãoC677TheterozigotanogenedaMTHFRapresentaramassociação
estatísticacomRSA.Aconcomitânciadestasduasalteraçõeséumnovoachadonoestudodefatores trombogênicosemabortoespontâneorecorrente.
PALAVRAS-CHAVE:
Metilenotetrahidrofolatoredutase(NADPH2).Trombofilia.Trombose.Síndromeantifos-folipídica.Anticorposanticardiolipina.
30. RaiR,ReganL,HadleyE,DaveM,CohenH.Second-trimester pregnancy loss is associated with activated C resistance. Br J Haematol.1996;92(2):489-90.
31. BalaschJ,ReverterJC,FábreguesF,etal.First-trimesterrepeated abortionisnotassociatedwithactivatedproteinCresistance.Hum Reprod.1997;12(5):1094-7.
32. BranchDW,SilverR,PierangeliS,vanLeeuwenI,HarrisEN. Antiphospholipidantibodiesotherthanlupusanticoagulantand anticardiolipinantibodiesinwomenwithrecurrentpregnancy loss,fertilecontrols,andantiphospholipidsyndrome.Obstet Gynecol.1997;89(4):549-55.
33. Preston FE, Rosendaal FR, Walker ID, et al. Increased fetal loss in women with heritable thrombophilia. Lancet. 1996;348(9032):913-6.
34. BucciarelliP,RosendaalFR,TripodiA,etal.Riskofvenous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated proteinCresistance:amulticentercollaborativefamilystudy. ArteriosclerThrombVascBiol.1999;19(4):1026-33.
35. DulícekP,ChrobákL,KalousekI,PesavováL,PeckaM,StránskyP. IsfactorVLeidenariskfactorforfetalloss?ActaMedica(Hradec Kralove).1999;42(3):93-6.
36. Ray JG, Laskin CA. Folic acid and homocyst(e)ine metabolic defectsandtheriskofplacentalabruption,pre-eclampsiaand spontaneous pregnancy loss: A systematic review. Placenta. 1999;20(7):519-29.
37. Murphy RP, Donoghue C, Nallen RJ, et al. Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase poly-morphism in pregnancy. ArteriosclerThromb Vasc Biol. 2000;20(1):266-70.
38. Lissak A, Sharon A, Fruchter O, Kassel A, Sanderovitz J, AbramoviciH.Polymorphismformutationofcytosinetothymine atlocation677inthemethylenetetrahydrofolatereductasegene isassociatedwithrecurrentearlyfetalloss.AmJObstetGynecol. 1999;181(1):126-30.
39. PhillipsMD.Interrelatedriskfactorsforvenousthromboembolism. Circulation.1997;95(7):1749-51.
40. ToppingJ,QuenbyS,FarquharsonR,MaliaR,GreavesM. Marked variation in antiphospholipid antibodies during pregnancy:relationshipstopregnancyoutcome.HumReprod. 1999;14(1):224-8.
Acknowledgments:ToMaryL.deSouzaQueiroz,BSc, PhD.,fromHemocentro,andtoMariadeFátimaSonatiand Aparecida Satiko Nagamati Pereira, from the Laboratory of Clinical Pathology, Universidade Estadual de Campinas (Unicamp),forprovidingsubstantialhelpinperforminganti-cardiolipinandinheritedthormbophiliatests.
Sourcesoffunding:Thisprojectwasfinanciallysupported byFundaçãodeApoioàPesquisadoEstadodeSãoPaulo (Fapesp),Brazil,grantno.98/12403-0.
Conflictofinterest:Notdeclared
Dateoffirstsubmission:December29,2003
Lastreceived:November26,2004